Kabeer Aziz is of AN2 Therapeutics, Inc.. Currently has a direct ownership of 40,919 shares of ANTX, which is worth approximately $49,511. The most recent transaction as insider was on Oct 10, 2025, when has been sold 10,367 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.9K
33.93% 3M change
n/a 12M change
Total Value Held $49,511

Kabeer Aziz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 10 2025
BUY
Grant, award, or other acquisition
-
10,367 Added 20.21%
40,919 Common Stock
Jul 10 2025
BUY
Grant, award, or other acquisition
-
11,875 Added 27.99%
30,552 Common Stock
Apr 10 2025
BUY
Grant, award, or other acquisition
-
9,705 Added 34.19%
18,677 Common Stock
Dec 19 2024
BUY
Grant, award, or other acquisition
-
8,972 Added 50.0%
8,972 Common Stock
KA

Kabeer Aziz

Menlo Park, CA

Track Institutional and Insider Activities on ANTX

Follow AN2 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANTX shares.

Notify only if

Insider Trading

Get notified when an An2 Therapeutics, Inc. insider buys or sells ANTX shares.

Notify only if

News

Receive news related to AN2 Therapeutics, Inc.

Track Activities on ANTX